Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Runfei Ointment case registration study in respiratory diseases with Qi and Yin deficiency and residual heat
ChiCTR2100045690Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Runfei Ointment in chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), bronchiectasis and 2 more, sponsored by China-Japan Friendship Hospital. Primary endpoints: Prescription habits of doctors, Clinical efficacy of Runfei Ointment and 1 more. Started Mar 2021; status: recruiting.
02
Drugs
Runfei Ointment
03
Conditions
chronic obstructive pulmonary disease (COPD)interstitial lung disease (ILD)bronchiectasispostinfectious coughcough variant asthma (CVA)
Beyond the preview
Go deeper on ChiCTR2100045690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045690.